Dr Mike Lynch, OBE, FREng, is the founder of Invoke Capital, a company which invests in fundamental European technologies. He has long been regarded as a visionary figure in technology, described by the Financial Times as “the doyen of European software” and by the Sunday Times as “Britain’s Bill Gates”. He advises the Prime Minister on matters of science policy through the Council on Science and Technology and is a Business Ambassador.
Dr Lynch has founded and advised a number of companies ranging from Neurodynamics to Blinkx. Dr Lynch is best known for founding Autonomy in 1996, the UK’s largest software company, member of the FTSE 100 with a market capitalisation of $11bn, and was its CEO for fifteen years until it was acquired by Hewlett Packard in 2011. He has invested in a number of start-ups, most recently Featurespace, and has also advised venture capital and private equity groups such as Apax Partners and the Carlyle Group.
During his career, Dr Lynch has received many awards and accolades. In January 2013 he was one of 100 people on The Times’ New Power List. In September 2012 he was inducted into the Digital Hall of Fame, alongside Tim Berners-Lee, Warren East and Stephen Fry. In 2011 he received the Outstanding Contribution award in the UKIT Industry awards and was named Most Influential Person in UK IT by Computer Weekly. He has been named Entrepreneur of the Year by Management Today magazine and by the CBI. He is an Honorary Fellow of Christ’s College, Cambridge, a Fellow of the Royal Academy of Engineering and Deputy Lieutenant of the County of Suffolk. In 2013 he joined the advisory board of the Newton Institute and in April 2014 he was named a Fellow for the Royal Society.
Alongside his entrepreneurial career, Dr Lynch has a number of board seats and advisory roles. He is currently a non-executive director of the British Library and Cambridge Enterprise. Previous roles include the BBC and Nesta. He is a council member of the Royal Academy of Engineering and of the Foundation for Science and Technology, of which he is also a trustee. He is a member of the advisory board of Tech City’s Investment Committee and of the “Create the Change” board at the Francis Crick Institute. He is an advisor to the Prince’s Trust technology group and a founding investor of Bridges Venturing, which is a social investment firm.
CEO, Pearl & Dean
Head, School of Biological, Biomedical and Environmental Sciences
Chair of Cognitive NeuroImaging
CEO, Cancer Research UK
Chair, Advisory, Conciliation and Arbitration Service (ACAS) Council